SCHEMBL1437405

SCHEMBL1437405

N#Cc1ncn(-c2cccc(Cl)c2F)c1N

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.52
HCAR1 Q9BXC0 7/20 0.49
IDO1 P14902 1/20 0.38
KAT2B Q92831 1/20 0.38
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
KDM4E B2RXH2 3/20 0.33
ALDH1A1 P00352 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
POLB P06746 1/20 0.33
RXRA P19793 3/20 0.32
GRIN1 Q05586 3/20 0.32
GRIN2B Q13224 3/20 0.32
PSMB8 P28062 1/20 0.32
GABRP O00591 1/20 0.32
GABRD O14764 1/20 0.32
GABRA1 P14867 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9894753 0.83 HCAR1 (0.49) PKMHCAR1IDO1KAT2BCYP1A2
SCHEMBL1437796 0.76 MDM2 (0.47) HCAR1GRIN1GRIN2B
SCHEMBL3612886 0.69 PKM (0.55) PKMHCAR1KDM4EALDH1A1
SCHEMBL986323 0.63 HCAR1 (0.40) HCAR1IDO1KAT2BALDH1A1RXRA
SCHEMBL2191670 0.63 HCAR1 (0.54) HCAR1IDO1KAT2BRXRAGRIN1
SCHEMBL14692466 0.63 NOTUM (0.53) HCAR1IDO1KAT2BCYP1A2CYP2D6
SCHEMBL15933292 0.63 HCAR1 (0.48) HCAR1IDO1KAT2BCYP1A2CYP2D6
SCHEMBL4055988 0.63 ADORA2A (0.41) PKMKDM4EALDH1A1POLB
SCHEMBL986522 0.62 P2RX7 (0.39) HCAR1IDO1KAT2BALDH1A1RXRA
SCHEMBL9050137 0.62 GABRG2 (0.47) CYP3A4CYP2C9GABRPGABRDGABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2470502-A1 TETRA-SUBSTITUTED HETEROARYL COMPOUNDS AND THEIR USE AS MDM2 AND/OR MDM4 MODULATORS Novartis AG (CH) 2012-07-04 EP disclosed
WO-2011023677-A1 TETRA-SUBSTITUTED HETEROARYL COMPOUNDS AND THEIR USE AS MDM2 AND/OR MDM4 MODULATORS NOVARTIS AG (CH) 2011-03-03 WO disclosed